Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across biomedical AI, cancer, cardiovascular diseases, immunity, age-related, rare and infectious diseases.

          Learn more

        • Biomedical AI
        • Cancer Innovations
        • Cardiovascular Research
        • Infection & Immunity
        • Rare Diseases & Gene Therapy
        • Laboratories
        • Impact
        • Technologies
        • Commercialisation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research.

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your will
        • Donate in memory
        • Advise on our research
  • Careers & students
        • Careers & Students

          Postdoctoral and postgraduate students can work alongside world-leading medical researchers within state-of-the-art research facilities.

        • Careers
        • Study opportunities
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events.

        • News
        • Statements
        • Events
        • Real stories
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges.

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Animals in research
        • Contact
  • Donate
    Centenary Institute > News > Centenary researcher wins prestigious cardiac prize

Centenary researcher wins prestigious cardiac prize

Date time 16 August, 2022
News Type News type Research News
Centenary Institute researcher and PhD candidate, Dr Julia Isbister, has been awarded the 2022 Ralph Reader Prize for Clinical Science by the Cardiac Society of Australia and New Zealand (CSANZ).

This prize, the most prestigious research award presented to young investigators by the CSANZ, was awarded to Dr Isbister at the CSANZ Annual Scientific Meeting held on the Gold Coast.

Dr Isbister won the prize for her research into ‘concealed cardiomyopathies’ – genetic abnormalities found in normal looking hearts which can lead to sudden cardiac death.

In her CSANZ meeting presentation, Dr Isbister noted that concealed cardiomyopathies (CCM) are an important cause of autopsy-inconclusive sudden cardiac death and that improved diagnosis of CCM can significantly improve care for surviving relatives.

“Family members who have lost a loved one to sudden cardiac death may share the same inherited abnormality. If so, genetic testing can identify the specific genetic change in some cases,” Dr Isbister said.

“Individuals who do have the genetic change can be closely followed and we can personalise care with the aim of preventing further tragedy in the family. Importantly, those who do not have the genetic change can be reassured and released from lifelong worry and follow-up.”

A cardiologist and PhD candidate based at the Centenary Institute’s Agnes Ginges Centre for Molecular Cardiology, Dr Isbister is interested in arrhythmia and inherited heart disease and her PhD work investigates genetic causes of sudden death and Brugada syndrome.

Themes

  • Cardiovascular Research

    Cardiovascular Research

Media enquires

For all media and interview enquiries, please contact Tony Crawshaw

Phone number Phone Number +61 402 770 403

Email Email t.crawshaw@centenary.org.au

Recent Stories

  • Medical research captured as art in annual image prize

    The intersection of science and art has once again been celebrated at the Centenary Institute, with the winners announced for its annual ‘When Art Meets Science Image Prize’.
    News Type: Media release
    Date 20 Jul 2026
  • Stem cell-coated contact lenses to be readied for clinical trials

    A breakthrough stem cell-coated contact lens designed to restore sight for people with corneal blindness will move closer to clinical use following a new Medical Research Future Fund (MRFF) grant awarded to a national team of researchers.
    News Type: Research News
    Date 15 Jul 2026
  • Centenary marks NAIDOC Week with special guest speaker

    The Centenary Institute marked NAIDOC Week 2026 with a special event celebrating this year's national theme, '50 Years of Deadly', which recognises five decades of honouring Aboriginal and Torres Strait Islander voices, achievements, leadership and culture.
    News Type: Community
    Date 08 Jul 2026
  • Protein form linked to severe COVID-19 and lung disease risk

    An international study involving the Centenary Institute and the University of Sydney has uncovered a previously hidden genetic factor that appears to help explain why some people develop lung fibrosis, a condition in which lung tissue becomes damaged and scarred, or experience severe COVID-19.
    News Type: Research News
    Date 01 Jul 2026

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About us
  • Governance
  • Corporate information

Research

  • Our researchers
  • News

Careers & studies

  • Career opportunities
  • Student opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement
  • Staff Intranet

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Contact Privacy

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram